Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

NCT05399485 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
496
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer